Table 1.
Recommendations for colorectal cancer screening across professional organizations[54]
|
Professional organization
|
Recommended ages for screening
|
Recommended screening tests
|
Other considerations
|
| U.S. Preventive Services Task Force (2016) | 50-75 | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | |
| U.S Multi-Society Task Force on Colorectal Cancer (2017) | 50-75 | FIT, colonoscopy (Tier 1)1 | Screening at age 45 yr for African Americans; AGA endorses Canadian guidelines on screening in setting of family history |
| National Comprehensive Cancer Network (2018) | 50-75 | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | Focused guidelines address screening for high-risk syndromes |
| American College of Physicians (2012) | 50-75 | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy, DCBE | |
| Canadian Task Force on Preventive Health Care (2016) | 50-74 | gFOBT, FIT, sigmoidoscopy | Weak recommendation for screening in ages 50-59 yr |
| American Cancer Society (2018) | 45-75 | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | Qualified recommendation for initiating screening at age 45 yr — uncertainty regarding ratio of benefits to harms |
Modified from Murphy[54].
Tier 2 tests include computed tomography colonography, fecal immunochemical tests-DNA, flexible sigmoidoscopy.
gFOBT: Guaiac-based fecal occult blood tests; FIT: Fecal immunochemical tests; CT: Computed tomography; AGA: American Gastroenterological Association.